Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| retinal rod cell | 9 studies | 42% ± 22% | |
| retinal cone cell | 8 studies | 69% ± 21% | |
| retinal bipolar neuron | 3 studies | 32% ± 12% | |
| OFF-bipolar cell | 3 studies | 21% ± 5% | |
| ON-bipolar cell | 3 studies | 27% ± 7% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| eye | 5 studies | 39% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| pancreas | 59% | 2.42 | 193 / 328 | 0% | 0 | 0 / 178 |
| adrenal gland | 51% | 1.75 | 132 / 258 | 0% | 0 | 0 / 230 |
| liver | 50% | 2.03 | 114 / 226 | 0% | 0.02 | 1 / 406 |
| spleen | 45% | 1.89 | 109 / 241 | 0% | 0 | 0 / 0 |
| lung | 40% | 1.34 | 230 / 578 | 0% | 0 | 0 / 1155 |
| prostate | 38% | 1.14 | 92 / 245 | 0% | 0 | 0 / 502 |
| muscle | 35% | 1.33 | 284 / 803 | 0% | 0 | 0 / 0 |
| blood vessel | 33% | 1.03 | 443 / 1335 | 0% | 0 | 0 / 0 |
| brain | 32% | 24.54 | 835 / 2642 | 0% | 0.01 | 1 / 705 |
| kidney | 30% | 0.92 | 27 / 89 | 0% | 0.00 | 1 / 901 |
| skin | 27% | 1.12 | 489 / 1809 | 0% | 0 | 0 / 472 |
| stomach | 26% | 0.86 | 95 / 359 | 0% | 0.00 | 1 / 286 |
| thymus | 26% | 0.73 | 167 / 653 | 0% | 0 | 0 / 605 |
| adipose | 24% | 0.74 | 294 / 1204 | 0% | 0 | 0 / 0 |
| intestine | 23% | 0.68 | 227 / 966 | 0% | 0 | 0 / 527 |
| heart | 21% | 0.59 | 184 / 861 | 0% | 0 | 0 / 0 |
| breast | 19% | 0.53 | 88 / 459 | 0% | 0.00 | 2 / 1118 |
| ovary | 17% | 0.51 | 31 / 180 | 0% | 0.01 | 1 / 430 |
| bladder | 14% | 0.48 | 3 / 21 | 0% | 0 | 0 / 504 |
| uterus | 14% | 0.34 | 23 / 170 | 0% | 0.00 | 1 / 459 |
| esophagus | 13% | 0.34 | 187 / 1445 | 0% | 0 | 0 / 183 |
| peripheral blood | 11% | 0.32 | 105 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 5% | 1.52 | 4 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007601 | Biological process | visual perception |
| GO_0016079 | Biological process | synaptic vesicle exocytosis |
| GO_0046928 | Biological process | regulation of neurotransmitter secretion |
| GO_0043195 | Cellular component | terminal bouton |
| GO_0031201 | Cellular component | SNARE complex |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0000149 | Molecular function | SNARE binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0019905 | Molecular function | syntaxin binding |
| Gene name | CPLX4 |
| Protein name | Complexin 4 Complexin-4 (Complexin IV) (CPX IV) |
| Synonyms | hCG_1776479 |
| Description | FUNCTION: Complexin that regulates SNARE protein complex-mediated synaptic vesicle fusion (By similarity). Required for the maintenance of synaptic ultrastructure in the adult retina (By similarity). Positively regulates synaptic transmission through synaptic vesicle availability and exocytosis of neurotransmitters at photoreceptor ribbon synapses in the retina (By similarity). Suppresses tonic photoreceptor activity and baseline 'noise' by suppression of Ca(2+) vesicle tonic release and the facilitation of evoked synchronous and asynchronous Ca(2+) vesicle release (By similarity). . |
| Accessions | K7EM04 Q7Z7G2 ENST00000587244.5 ENST00000299721.3 |
